Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemia.
Capizzi
R L
RL
Powell
B L
BL
Cooper
M R
MR
Rathmell
J P
JP
White
J C
JC
Muss
H B
HB
Richards
F
F
Jackson
D V
DV
Stuart
J J
JJ
White
D R
DR
D000208:Acute Disease; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use* / Q000633:toxicity; D001215:Asparaginase / Q000008:administration & dosage / Q000633:toxicity*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism; D002460:Cell Line; D003561:Cytarabine / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007940:Leukemia L5178 / Q000378:metabolism; D051379:Mice
D003561:Cytarabine; D001215:Asparaginase